MiRNAs at the Crossroads Between Innate Immunity and Cancer: Focus on Macrophages

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2018 Feb 9

PMID 29419779

Citations 23

Authors

Graziella Curtale

Affiliations

Soon will be listed here.

Abstract

Innate immune cells form an integrative component of the tumor microenvironment (TME), which can control or prevent tumor initiation and progression, due to the simultaneous processing of both anti- and pro-growth signals. This decision-making process is a consequence of gene expression changes, which are in part dependent on post-transcriptional regulatory mechanisms. In this context, microRNAs have been shown to regulate both recruitment and activation of specific tumor-associated immune cells in the TME. This review aims to describe the most important microRNAs that target cancer-related innate immune pathways. The role of exosomal microRNAs in tumor progression and microRNA-based therapeutic strategies are also discussed.

Citing Articles

Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.

He S, Song W, Cui S, Li J, Jiang Y, Chen X Cell Oncol (Dordr). 2023; 46(6):1731-1746.

PMID: 37402945 PMC: 10697876. DOI: 10.1007/s13402-023-00839-0.

Intersections between innate immune response and gastric cancer development.

Villarroel-Espindola F, Ejsmentewicz T, Gonzalez-Stegmaier R, Jorquera R, Salinas E World J Gastroenterol. 2023; 29(15):2222-2240.

PMID: 37124883 PMC: 10134417. DOI: 10.3748/wjg.v29.i15.2222.

Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target.

Yarahmadi A, Sohan R, McAllister B, Caromile L Mol Cell Oncol. 2022; 9(1):2136476.

PMID: 36313480 PMC: 9601542. DOI: 10.1080/23723556.2022.2136476.

MicroRNAs: immune modulators in cancer immunotherapy.

Xing Y, Wang Z, Lu Z, Xia J, Xie Z, Jiao M Immunother Adv. 2022; 1(1):ltab006.

PMID: 35919742 PMC: 9327120. DOI: 10.1093/immadv/ltab006.

miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.

Feng Y, Li Y, Zhang Y, Zhang B, Zhao H, Zhao X J Neuroinflammation. 2021; 18(1):133.

PMID: 34118948 PMC: 8196447. DOI: 10.1186/s12974-021-02181-4.

References

Kobayashi M, Salomon C, Tapia J, Illanes S, Mitchell M, Rice G . Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014; 12:4. PMC: 3896684. DOI: 10.1186/1479-5876-12-4. View

Martinez-Nunez R, Louafi F, Sanchez-Elsner T . The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 2010; 286(3):1786-94. PMC: 3023473. DOI: 10.1074/jbc.M110.169367. View

Chen S, Wang L, Fan J, Ye C, Dominguez D, Zhang Y . Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism. Cancer Res. 2014; 75(3):519-31. PMC: 4315710. DOI: 10.1158/0008-5472.CAN-14-2331. View

Soon P, Kiaris H . MicroRNAs in the tumour microenvironment: big role for small players. Endocr Relat Cancer. 2013; 20(5):R257-67. DOI: 10.1530/ERC-13-0119. View

Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland C . Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut. 2015; 66(4):654-665. PMC: 4919275. DOI: 10.1136/gutjnl-2014-308737. View

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

Kim Y, Kim B, Kim V . Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. Proc Natl Acad Sci U S A. 2016; 113(13):E1881-9. PMC: 4822641. DOI: 10.1073/pnas.1602532113. View

Wu X, Zou Y, He X, Yuan R, Chen Y, Lan N . Tumor-infiltrating mast cells in colorectal cancer as a poor prognostic factor. Int J Surg Pathol. 2012; 21(2):111-20. DOI: 10.1177/1066896912448836. View

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H . Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest. 2008; 118(10):3367-77. PMC: 2528912. DOI: 10.1172/JCI35213. View

10.

Seoane J, Gomis R . TGF-β Family Signaling in Tumor Suppression and Cancer Progression. Cold Spring Harb Perspect Biol. 2017; 9(12). PMC: 5710110. DOI: 10.1101/cshperspect.a022277. View

11.

Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F . Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol. 2007; 214(1):17-24. DOI: 10.1002/path.2251. View

12.

Martinez F, Gordon S . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13. PMC: 3944738. DOI: 10.12703/P6-13. View

13.

Zhou W, Fong M, Min Y, Somlo G, Liu L, Palomares M . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25(4):501-15. PMC: 4016197. DOI: 10.1016/j.ccr.2014.03.007. View

14.

Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View

15.

Taganov K, Boldin M, Chang K, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-6. PMC: 1567904. DOI: 10.1073/pnas.0605298103. View

16.

Dominguez G, Condamine T, Mony S, Hashimoto A, Wang F, Liu Q . Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody. Clin Cancer Res. 2016; 23(12):2942-2950. PMC: 5468499. DOI: 10.1158/1078-0432.CCR-16-1784. View

17.

Street S, Cretney E, Smyth M . Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 2001; 97(1):192-7. DOI: 10.1182/blood.v97.1.192. View

18.

Topalian S, Drake C, Pardoll D . Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015; 27(4):450-61. PMC: 4400238. DOI: 10.1016/j.ccell.2015.03.001. View

19.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

20.

Jeong S, Kim J, Lee C, Park Y, Kim S, Yoon S . Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals. Immunobiology. 2015; 222(1):55-65. DOI: 10.1016/j.imbio.2015.11.010. View